Operose Advisors’s Ametek AME Stock Holding History

Operose Advisors’s Portfolio AME Stock Details AME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20	Closed	-$3.6K	–	390
2024 Q4	$3.6K	Buy	+20	New	+$3.64K	﹤0.01%	374

Other funds holding AME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Operose Advisors's AME Position: Q1 2025 in Review

Operose Advisors sold out of Ametek (AME) in Q1 2025, closing a stake of 20 shares — an estimated $3.6K sold.

Operose Advisors first reported a position in AME in Q4 2024 and held it in 1 quarter. The position peaked at $3.6K in Q4 2024. 1,001 funds tracked by Wall St. Rank hold AME as of Q1 2025.

Operose Advisors reported no remaining Ametek position as of Q1 2025 after selling out during the quarter.
Operose Advisors sold 20 Ametek shares in Q1 2025, an estimated $3.6K.
Operose Advisors first reported a position in Ametek in Q4 2024 and held it in 1 quarter.
Operose Advisors's Ametek position peaked at $3.6K in Q4 2024.
1,001 funds tracked by Wall St. Rank held Ametek as of Q1 2025.

Based on Operose Advisors's 13F filing for Q1 2025, filed 12 May 2025.